MedTrace Logo

Nasal Findings in Reactive Airway Diseases

NCT03131323 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-04-27

No results posted yet for this study

Summary

Reactive airway diseases is a common respiratory diseases affecting 1-18% of the population in different countries. It carries a significant burden to children, their families, the healthcare system and the overall community.The purpose of the study is to delineate the prevalence of abnormal nasal finding in wheezy children and evaluate the role of the endoscopic examination of the nose in evaluation and management of a wheezy child.Patients and methods:The study will be conducted as a prospective case series including all children having chest wheezes, aged from two years to eighteen years, attending emergency unit of assuit university children hospital

Conditions

  • Reactive Airway Disease
  • Wheezing

Interventions

PROCEDURE

• Flexible fiberopticnasopharyngoscope

. II- Equipments: * Flexible fiberopticnasopharyngoscope, 2.7 mm in diameter and fiberoptic light cable. * The camera: fitted with Three-CCD (Charged Couple Device) sensors. * A high resolution monitor. * A recording unit. III- Positioning:Infants and small children have to be held by a parent or an adult. Older children and adolescents usually tolerate office flexible nasopharyngoscopy once the procedure is explained. If office flexible nasopharyngoscopy failed because the child is not cooperative or if there is excessive secretions, general anesthesia may be required \[8\]. IV- Technique: Lubricant gel will be applied to the tip of the endoscope which will be now will be passed along the floor of the nose, between the inferior turbinate and the nasal septum, till it reaches the nasopharynx. Now the entire nose and the nasopharynx could be thoroughly examined and any abnormal findings could be detected and documented.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-07-01
Completion
2018-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03131323 on ClinicalTrials.gov